Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Science Advances|August 22, 2025
Characterization of the glycoproteins of fish and amphibian influenza B-like virusesGagandeep Singh, Jiachen Huang, Disha Bhavsar, et al.Science Advances|August 15, 2025
Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EMJames A Ferguson, Sai Sundar Rajan Raghavan, Garazi Peña Alzua, et al.Malaria Journal|August 4, 2012
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquineBrandon S Pybus, Jason C Sousa, Xiannu Jin, et al.Nature Communications|February 2, 2025
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genesTing-Hui Lin, Chang-Chun David Lee, Monica L Fernández-Quintero, et al.Nature Communications|August 1, 2025
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3Gyunghee Jo, Seiya Yamayoshi, Krystal M Ma, et al.Science Advances|March 28, 2025
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineagesCaroline K Page, Justin D Shepard, Sean D Ray, et al.Structure (London, England : 1993)|September 27, 2024
Assessing AF2's ability to predict structural ensembles of proteinsJakob R Riccabona, Fabian C Spoendlin, Anna-Lena M Fischer, et al.Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.Antibodies (Basel, Switzerland)|October 24, 2023
Structure and Dynamics Guiding Design of Antibody Therapeutics and VaccinesMonica L Fernández-Quintero, Nancy D Pomarici, Anna-Lena M Fischer, et al.Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccineJiaojiao Liu, Sydney Gang, Caroline Kikawa, et al.Pageof 3